Showing results (61-70 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|October 9, 2004
Predictors of virological response to atazanavir in protease inhibitor-experienced patientsAna Barrios, Ana Lucía Rendón, Oscar Gallego, et al.HIV Clinical Trials|October 30, 2018
Exercise training reduces oxidative stress in people living with HIV/AIDS: a pilot studyLuís Fernando Deresz, Cinthia Maria Schöler, Paulo Ivo Homem Júnior de Bittencourt, et al.HIV Clinical Trials|October 30, 2018
Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) StudyJoshua Wynne, Rosemary Muwawu, Michael C Mubiru, et al.HIV Clinical Trials|June 13, 2008
Virologic success in an urban HIV clinic: outcome at 12 months in patients who were HAART naïveEdward Blanchard, Olga M Klibanov, Peter Axelrod, et al.HIV Clinical Trials|April 30, 2004
Simplified therapy with zidovudine, lamivudine, and abacavir for very nonadherent, treatment-failing patientsHernando Knobel, Gabriel Vallecillo, Ana Guelar, et al.HIV Clinical Trials|April 30, 2004
Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndromeI Poizot-Martin, C Marimoutou, F Vion-Dury, et al.HIV Clinical Trials|March 6, 2004
Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individualsShyam Kottilil, Shyla Jagannatha, Amy Lu, et al.HIV Clinical Trials|September 30, 2005
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapyRodger D MacArthur, George Perez, Sharon Walmsley, et al.HIV Clinical Trials|June 29, 2005
Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patientsGraham H R Smith, Mohamed-Rachid Boulassel, Marina Klien, et al.Pageof 68